Servier acquires Day One Biopharma
Servier agreed to acquire Day One Biopharma. Reported deal value: $2.5B. Status: Pending. Sector: Pharmaceuticals. Target headquarters context: Brisbane, California, United States.
This page summarizes publicly available information about the transaction as of 2026-03-06. Figures and status may change as filings and press coverage update.
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier rare oncology portfolio Back to news Servier and Day One Biopharmaceuticals announce acquisition to expand Servier rare oncology portfolio 6 March 2026 Acquisition positions Servier as a leader in pediatric low-grade glioma and expand s its pipeline with programs targeting adult and pediatric cancers with high unmet needs
Deal timeline
This transaction is classified in Pharmaceuticals with a reported deal value of $2.5B. Figures and status may change as sources update.